Target intelligence / Profile preview

Synovial fluid viscoelasticity

Molecular classification
Other
01

Overview

Synovial fluid viscoelasticity refers to the rheological behavior of the fluid within diarthrodial joints, characterized by its ability to act as both a viscous lubricant and an elastic shock absorber. This dual functionality is primarily mediated by high-molecular-weight hyaluronic acid (HA) and the glycoprotein lubricin, which are secreted by synoviocytes and chondrocytes (StatPearls, 2023). Under low-frequency strain, the fluid behaves like a viscous liquid to reduce friction during slow movement; under high-frequency strain, it behaves like an elastic solid to protect the articular cartilage from mechanical impact (PubMed, 2021). In pathological conditions such as osteoarthritis, the concentration and average molecular weight of HA are significantly diminished due to dilution by effusion and degradation by reactive oxygen species and enzymes (NIH, 2022). This loss of viscoelasticity results in increased mechanical wear on the joint surfaces and contributes to the cycle of inflammation and pain (PubMed, 2020). Therapeutic strategies known as viscosupplementation involve the intra-articular injection of exogenous HA derivatives to temporarily restore the fluid's rheological properties and stimulate endogenous HA production (Arthritis Foundation, 2023). While not a single molecular target, the restoration of synovial fluid viscoelasticity is a primary goal in the non-surgical management of joint degeneration.

Other names
Joint fluid rheologySynovial rheologyViscoelastic properties of synovial fluidSynovial fluid viscosity
02

Mechanism of action

Viscosupplementation (restoration of rheological properties and lubrication through intra-articular injection of high-molecular-weight hyaluronic acid)

03

Biological functions

Joint lubricationShock absorptionLoad bearingCartilage protectionNutrient transport
04

Disease associations

OsteoarthritisRheumatoid arthritisTraumatic arthritisJoint effusion
05

Safety considerations

Post-injection flarePseudoseptic reactionIatrogenic joint infectionInjection site painHypersensitivity to avian-derived products
06

Interacting drugs

Sodium hyaluronate

6 more in the full profile.

07

Biomarkers

Synovial fluid viscosityHyaluronic acid molecular weightHyaluronic acid concentrationLubricin levelsC-terminal telopeptide of type II collagen (CTX-II)

Beyond the preview

Go deeper on Synovial fluid viscoelasticity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synovial fluid viscoelasticity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call